Congratulations to Wuhan Biying Biotechnology Co., Ltd. on its 10 million Series A financing by Huzhou Jinda Eleven Venture Investment Partnership (Limited Partnership).

The company's strategic investment of 10 million is an important step in the development strategy of Biobaying, we will rely on this financing to continue to expand the market, increase research and development, continuous innovation, and strive to become the benchmark in the field of orthopedic 3D external fixation printing, to promote the digital medical continued to make efforts.